A B S T R A C T Many of the clinical features of paraproteinemia result from impairment of blood flow through the vascular tree because of blood hyperviscosity. Studies were carried out in 65 patients with serum paraproteins (31 with IgG, 25 with IgM, and 9 with IgA) to examine the relationship between the blood viscosity and the frequency of selected clinical features. The blood and plasma viscosities were measured at low rates of shear. Blood hyperviscosity was present in 91% of the patients and plasma hyperviscosity in 75% of the patients. In each of the three immunoglobulin classes both the blood and plasma viscosities increased logarithmically with the paraprotein concentration being greatest in the case of IgM. In addition, the relationship between the hematocrit and the logarithm of blood viscosity tended to be linear at any given protein concentration. In patients with very high levels of paraprotein the blood viscosity was modified by low hematocrits; the latter was below 30 in 70% of patients in whom the concentration of paraprotein was above 4 g/100 ml. The prevalence of clinical complications involving the retinal circulation, the peripheral vascular system, and the central nervous system increased markedly with increasing blood viscosity, measured at 0.18 s-1. One or more of these regions was affected in greater than 80% of patients with blood viscosity above 60 centipoise and in less than 23% ofpatients with blood viscosity below 40 centipoise. These observations illustrate the complex relationship between blood viscosity, concentration of paraprotein, immunoDr. M. A.
INTRODUCTION
Many of the clinical features of paraproteinemia are considered to result from the increased resistance to blood flow associated with blood hyperviscosity. The documentation of such changes in viscosity has been reported, and in addition a number of studies have attempted to define the relationship between the viscosity and the frequency of vascular complications (1) (2) (3) (4) (5) . However, the results have been variable and inconclusive. This could be attributed to the measurement of the serum viscosity alone thereby neglecting the important contributions of erythrocytes to the viscosity of whole blood.
The blood viscosity is also a function of the rate of shear. The strength of interaction between the plasma proteins (especially immunoglobulin and fibrinogen) and the erythrocytes, which is a major determinant of the blood viscosity, can best be assessed at low rates of shear (6) . Actual shear rates in the micro circulation vary both spatially and temporally and are difficult to determine. Blood flow in the micro circulation is intermittent and hence conditions near or at zero shear rate may exist normally (7) . The thesis of the present study is that clinical complications of blood hyperviscosity in paraproteinemia result from impedence of the micro circulation by increased erythrocyte aggregation induced by the paraprotein. This argument is supported by the studies of Rosenblum and Asofsky (8) which demonstrated that the blood flow in the micro circulation of macroglobulinemic mice is inversely related to the blood viscosity. In addition profound intravascular erythrocyte aggregation was found to be dependent on the level of blood viscosity measured in vitro (9) . Since the degree of erythrocyte aggregation can best be assessed in vitro by measuring the whole blood viscosity at low shear rates (6, 10, 11) , a shear rate was selected for whole blood (0.18 s-1) and plasma (1.5 s-1) which was low and yet within the technical limitations of the instrument used.
From the variety of viscometers available, the rotational viscometer fulfilled the requirement for accurate control of shear rate, whereas the capillary tube viscometer did not. In particular, the capillary tube viscometer was quite unsuitable for measurement of whole blood viscosity, one of the principal aims of this paper.
The purpose of the present study was to measure the whole blood and plasma viscosity in paraproteinemia at low rates of shear and to correlate this with the incidence of clinical features of the hyperviscosity syndrome for each of the three major immunoglobulin classes. (18) indicates that although the relationship is sometimes expressed as a power polynomial function, the latter includes the solution for hematocrits from 0 to 95. Close inspection of the data plots, with respect to whole blood viscosity in man (18, 19) indicates that over the hematocrit range 30-50 the relationship between log viscosity and hematocrit is closely linear, although there was an important deviation from this simple relationship at higher hematocrits (i.e. >50).
METHODS
The plasma viscosity of 22 normal subjects was also measured. Plasma hyperviscosity is defined as a value above the mean + 2SD limit determined for normal plasma.
Plasma volume. The plasma volume was computed by using I125 albumin dilution (Volemetron, Ames Co., Elkhart, Ind. 4 g/100 ml whereas 41% of patients in the IgG class and only 28% of patients in the IgM class had a paraprotein concentration above this level. Fig. 1 shows that the whole blood viscosity is dependent on the concentration of paraprotein-an increase in concentration being associated with a disproportionate increase in blood viscosity measured at the same hematocrit. This dependence is illustrated by the progressive increase in the viscosity above from the normal range with increasing concentration of paraprotein.
Effect of hematocrit on blood viscosity. Fig. 1 also indicates the important influence of hematocrit on viscosity in paraproteinemia. The relationship between blood viscosity and hematocrit follows approximately a log-normal distribution. IgA, x; IgM, E.
It can also be seen that with increasing paraprotein concentrations there is a progressive decrease in the hematocrit. In the 0-2 g/100 ml range, 14 (93%) of the 15 patients studied had a venous hematocrit above 30 , whereas of the 26 patients with a concentration of paraprotein above 4 gI100 ml only 8 (31%) had a venous hematocrit above 30 . The whole blood viscosity at high concentrations of paraprotein is therefore modified by a reduced hematocrit.
There were four patients with IgG paraproteinemia in whom the concentration was >6 g/100 ml, whereas there was only one patient in each of the IgM and IgA classes in whom the concentration was above this level. This is an explanation for the broad scatter of results in the IgG class at the >4 g/100 ml concentration range (Fig. 1) particularly in the micro circulation. The promotion of erythrocyte aggregation by plasma globulins has been repeatedly emphasized (6, 8, 10, 13, 27) and the greatly increased erythrocyte sedimentation rate, which is characteristic of paraproteinemia, supports these conclusions.
The measurement of the blood viscosity provides an assessment of the degree of interaction between the various components of blood (6, 9, 11) fore, of the intrinsic resistance to flow. In support of this concept are the observations by Rosenblum and Asofsky (8, 9, 28) (18, 22, (24) (25) (26) . The present results also indicate that, in general, this relationship between viscosity and hematocrit holds true for paraproteinemia of the IgM, IgG, and IgA classes, thus confirming the previous observations for IgM (29) extending these to the other major immunoglobulin classes. The influence of hematocrit on blood viscosity is seen to be most marked at high concentrations of protein, particularly in the IgM class. This finding contrasts with the relationship defined by Mannik (29) who found that the slope of the regression line relating hematocrit to log viscosity tended to decrease as the macroglobulin concentration increased. This difference may be duie, at least in part, to the higher slhear rate used in the latter study.
An additional finding in these studies is the lower hematocrit found in those patients having a higher concentration of paraprotein. This may be partly a result of plasma hypervolemia as indicated by the linear relationship found between increasing plasma volume and increasing plasma viscosity. A number of other investigators (30) (31) (32) (33) (34) (35) have also reported plasma hypervolemia in paraproteinemia. Therefore the reduced hematocrit in these patients can be considered, at least in part, as a dilutional anemia. Attempts to correct this anemia by transfusion can precipitate very high levels of blood viscosity which may be dangerous to the patient. The blood viscosity should be carefully monitored during procedures such as plasmapheresis and blood transfuisions becauise of the important contribution of the hematocrit to the blood viscosity in these patients.
The most frequently reported clinical complications of hyperviscosity are those involving the retinal circulation, the central nervous system, hemostatic mechanisms, cardiac function, and the peripheral vascular system. In the present study the prevalence of involvement of the central nervous system, retinal circulation, and peripheral vascuilar system increased progressively with increasing blood viscosity in each of the three immunoglobulin classes. However, other less frequent complications of paraproteinemia (e.g. amyloid, plasma cell infiltration, and neuropathy) cannot be excluded as causative factors.
The final clinical expression of blood hyperviscosity will be influenced by various modifying factors such as primary vessel wall disease, the local temperature and pressure gradients, and tendency of the paraprotein to cryoprecipitation.
A number of investigators (1-3, 5, 36) have attempted to correlate the clinical abnormalities in paraproteinemia with the serum or plasma viscosity. Such studies disregard the important rheological implications of both the hematocrit level and differing cell-protein interactions. Their collective influence on microvascular flow will only be indicated by the whole blood viscosity at low rates of shear. The findings in the present study demonstrate the relationship between blood viscosity in paraproteinemia and protein concentration, immunoglobulin class, and hematocrit. The results emphasize that the frequency of clinical vascular complications in these patients is high and is related to the blood viscosity level. The finding of blood hyperviscosity will provide the basis for a more accurate interpretation of clinical features and supports an increased resistance to blood flow rather than a primary disease process. The nonlinear dependence of the blood viscosity on both the protein concentration and hematocrit forms the basis for constructing rational therapeutic guidelines in the management of the individual patient. Attention is also directed by this study to the protective nature of plasma hypervolemia with a low venous hematocrit and to the potential hazards involved in such procedures as blood transfusion and plasmapheresis when elevations in the hematocrit can cause marked increases in blood viscosity.
